Therma Bright (TSE:THRM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Therma Bright Inc. congratulates John Patton, Ph.D., Chairman of their strategic investment partner InStatin, on receiving the Charles G. Thiel Award for his contributions to respiratory drug delivery. Patton’s notable career includes founding several biotech companies and achieving major industry milestones. Therma Bright, which holds significant shares in InStatin and InVixa, is optimistic about their collaborative development of innovative inhalant solutions for lung conditions.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue